Shotel Medical
Private Company
Funding information not available
Overview
Shotel Medical is a commercial-stage orthopedic device company that has developed a novel, curved intramedullary nail system for ankle fusion surgery. Its first FDA-cleared product, the Shotel™ Ankle Arthrodesis Nail System, targets end-stage ankle arthritis with a minimally invasive approach intended to promote faster recovery. The company is actively marketing to surgeons and hospitals while seeking investment to support commercialization and future pipeline development. Its value proposition centers on a unique device design, strong intellectual property, and a focus on improving surgical outcomes for a growing patient population.
Technology Platform
Proprietary curved intramedullary nail design for minimally invasive bone fixation, inspired by a sickle-shaped blade, enabling unique surgical approaches in foot and ankle arthrodesis.
Opportunities
Risk Factors
Competitive Landscape
The foot and ankle orthopedic device market is highly competitive, dominated by large players like Stryker, Zimmer Biomet, Smith & Nephew, and specialized firms like Paragon 28. Competition is based on surgeon relationships, clinical data, product portfolio breadth, and price. Shotel's niche is a novel curved nail design, but it must compete against extensive portfolios of plates, screws, straight nails, and alternative fusion systems.